amylin glp-1 dual agonist Identification and utility exploration of a highly potent and long-acting bullfrog analogue in GLP-1 and combination therapy Combined GLP-1/amylin analog bests monotherapy

Provided the research supporting the use of DSIP nasal spray, some researchers may want to opt for a nasal spray over injection

It reduces total peptide usage by about 15% and provides weekly micro-washouts that protect receptor sensitivity during longer cycles

Lin J et al

Single Vial, Five Pack Share your love Related products Quick view icon GLP-Reta Starting at $115.00 Quick view icon KPV Starting at $70.00 Quick view icon BPC-157 Starting at $35.00 SOLD OUTQuick view icon BPC-157 (Oral) Starting at $175.00

This matters as a new cornerstone therapy in type 2 diabetes (T2DM), glucagon-like peptide-1 receptor agonists (GLP-1), are entering broader use, necessitating a deeper dive into how this treatment interacts, directly or indirectly, with pathways influenced by sex hormones